Their effectiveness in the long run requires their combination with the following: Healthy eating habits Regular physical activity Ongoing medical supervision The weight loss from GLP-1 drugs must be slow and sustainable rather than quick and erratic
MalavazosAEIacobellisGDozioEBasilicoSDi VincenzoADubiniCet alHuman epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies
, Monuki, E
In these trials, participants were randomised to the GLP-1RA in question or placebo, and all participants were treated with standard of care with the possibility of adding non-incretin-based diabetes therapies
Therapies that prevent cardiovascular events, kidney disease, liver disease, sleep apnea, or even neurodegeneration could unlock massive new markets
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study
